PATENT CLAIM ANALYSIS

Application Number: 15941644
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "408000"]

Abstract:
Disclosed herein are sustained release Liothyronine oral capsule formulations, methods of making the formulations and use to treat hypothyroidism, a thyroid deficient disease state, or thyroid dysfunction.

Claim (Index 13):
The capsule formulation of  claim 1 , wherein the capsule comprises a fill weight that is no more than 325 mg, specifically no more than 275 mg, more specifically no more than 225 mg, and yet more specifically no more than 200 mg.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.14815
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15912438', '13498751', '12097163', '14776386', '14062759']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7401711866614885
- 35 USC 102 Novelty (BERT): 0.5058331150649901
- Combined Prediction Score: 0.7167373795018387
- Mean Citation Score: 224.737068
- Max Citation Score: 237.49814
- Similarity Product: 153.49260313081027

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test